Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 15,500 shares at $14.68 ($228K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $228k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $856K | — | Filing → |